Cscec Scimee Sci.&Tech. Co.,Ltd (SHE:300425)
China · Delayed Price · Currency is CNY 5.26
-0.02 (-0.38%)
Feb 11, 2026, 3:04 PM CST
SHE:300425 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,652 | 1,520 | 1,661 | 1,702 | 1,445 | 1,231 |
Other Revenue | 16.34 | 16.34 | 10.03 | 17.47 | 16.37 | 10.65 |
| 1,669 | 1,537 | 1,671 | 1,720 | 1,461 | 1,242 | |
Revenue Growth (YoY) | -3.03% | -8.06% | -2.80% | 17.66% | 17.66% | 0.83% |
Cost of Revenue | 1,242 | 1,068 | 1,071 | 1,141 | 928.79 | 764.15 |
Gross Profit | 426.95 | 468.34 | 600.09 | 578.2 | 532.67 | 477.92 |
Selling, General & Admin | 253.76 | 273.81 | 289.8 | 275.7 | 270.47 | 249.7 |
Research & Development | 57.3 | 50.47 | 58.53 | 51 | 51.43 | 39.73 |
Other Operating Expenses | 9.52 | 3.49 | 7.29 | 5.24 | 2.52 | -2.84 |
Operating Expenses | 382.7 | 387.33 | 388.16 | 381.73 | 330.72 | 304.64 |
Operating Income | 44.25 | 81.01 | 211.93 | 196.47 | 201.96 | 173.27 |
Interest Expense | -29.29 | -33.89 | -30.48 | -26.4 | -23.35 | -23.08 |
Interest & Investment Income | 7.56 | 3.53 | 9.55 | 6.59 | 5.85 | 8.73 |
Currency Exchange Gain (Loss) | 0.12 | 0.12 | -0.07 | -0.38 | -0.03 | -0.22 |
Other Non Operating Income (Expenses) | 0.63 | 5.53 | -3.25 | 7.11 | 1.3 | -3.78 |
EBT Excluding Unusual Items | 23.27 | 56.31 | 187.68 | 183.39 | 185.73 | 154.92 |
Gain (Loss) on Sale of Investments | - | -0.18 | -0.58 | - | - | - |
Gain (Loss) on Sale of Assets | 32.58 | 33.11 | 2.11 | 6.83 | 0.64 | 2.25 |
Asset Writedown | -0.48 | -0.03 | -3.04 | 0 | 0.01 | 0.09 |
Other Unusual Items | 12.7 | 11.26 | 9.96 | 16.2 | 16.27 | 27.98 |
Pretax Income | 68.07 | 100.47 | 196.12 | 206.42 | 202.66 | 185.25 |
Income Tax Expense | 3.46 | 6.14 | 16.64 | 7.7 | 18.6 | 11.49 |
Earnings From Continuing Operations | 64.61 | 94.33 | 179.48 | 198.72 | 184.06 | 173.75 |
Minority Interest in Earnings | -2.06 | -6.13 | -12.03 | -7.1 | -3.72 | -4.33 |
Net Income | 62.55 | 88.2 | 167.45 | 191.62 | 180.35 | 169.42 |
Net Income to Common | 62.55 | 88.2 | 167.45 | 191.62 | 180.35 | 169.42 |
Net Income Growth | -57.03% | -47.33% | -12.62% | 6.25% | 6.45% | 8.37% |
Shares Outstanding (Basic) | 679 | 679 | 676 | 676 | 676 | 676 |
Shares Outstanding (Diluted) | 679 | 679 | 678 | 676 | 676 | 676 |
Shares Change (YoY) | -0.00% | 0.20% | 0.26% | 0.03% | -0.01% | -0.23% |
EPS (Basic) | 0.09 | 0.13 | 0.25 | 0.28 | 0.27 | 0.25 |
EPS (Diluted) | 0.09 | 0.13 | 0.25 | 0.28 | 0.27 | 0.25 |
EPS Growth | -57.03% | -47.43% | -12.84% | 6.22% | 6.46% | 8.62% |
Free Cash Flow | 63.7 | 40.49 | -62.39 | -171.34 | -66.06 | 41.56 |
Free Cash Flow Per Share | 0.09 | 0.06 | -0.09 | -0.25 | -0.10 | 0.06 |
Dividend Per Share | 0.026 | 0.026 | 0.050 | 0.057 | 0.055 | 0.050 |
Dividend Growth | -47.54% | -47.54% | -13.05% | 3.64% | 10.00% | -0.02% |
Gross Margin | 25.59% | 30.48% | 35.90% | 33.62% | 36.45% | 38.48% |
Operating Margin | 2.65% | 5.27% | 12.68% | 11.43% | 13.82% | 13.95% |
Profit Margin | 3.75% | 5.74% | 10.02% | 11.14% | 12.34% | 13.64% |
Free Cash Flow Margin | 3.82% | 2.63% | -3.73% | -9.96% | -4.52% | 3.35% |
EBITDA | 148 | 182.23 | 309.77 | 290.22 | 274.56 | 234.54 |
EBITDA Margin | 8.87% | 11.86% | 18.53% | 16.88% | 18.79% | 18.88% |
D&A For EBITDA | 103.75 | 101.21 | 97.84 | 93.75 | 72.6 | 61.26 |
EBIT | 44.25 | 81.01 | 211.93 | 196.47 | 201.96 | 173.27 |
EBIT Margin | 2.65% | 5.27% | 12.68% | 11.43% | 13.82% | 13.95% |
Effective Tax Rate | 5.08% | 6.11% | 8.48% | 3.73% | 9.18% | 6.21% |
Revenue as Reported | 1,669 | 1,537 | 1,671 | 1,720 | 1,461 | 1,242 |
Advertising Expenses | - | 4.13 | 2.68 | 3.54 | 4.07 | 3.27 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.